Skip to main content

Translatable Efficacy & Safety Testing of mAb, Bispecific, & CAR T Therapies

Published Date

Immune humanized platforms are ideal for lead optimization and safety data sets supporting Investigational New Drug (IND) applications. In this webinar, Brian Soper, Ph.D. presents preclinical data demonstrating:

  • Monoclonal antibody-based human immune modulation
  • Donor-specific differences in bispecific antibody-mediated tumor efficacy and cytokine release
  • CAR T cell-mediated tumor efficacy and safety